// App-Quantinova.ai

: Incidentally Detected Venous Thromboembolism in Cancer Patients: Results from the Hokusai VTE Cancer Trial

Researchers

Presenter

  • F. Mulder

Principal Investigators

  • N. vanEs

  • M. Carrier

  • F. Bosch

  • A. Segers

  • N. Kraaijpoel

  • M. Grosso

  • P. Verhamme

  • T.-F. Wang

  • S. Middeldorp

  • M. di Nisio

  • C. Ay

  • G. Raskob

  • H. Buller

Medical Centers

  • Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Department of Vascular Medicine, Amsterdam, the Netherlands

  • Amsterdam Cardiovascular Sciences, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • ITREAS, Amsterdam, the Netherlands

  • Daiichi Sankyo Co., Ltd., Basking Ridge, United States

  • University of Leuven, KUL, Leuven, Belgium

  • Ohio State University Medical Center, Hematology, Columbus, United States

  • Padua, Department of Medicine and Ageing Sciences University ‘G.D'Annunzio’, Chieti, Italy

  • Medical University of Vienna, Vienna, Austria

  • Oklahoma Medical Research Foundation, Oklahoma City, United States

Locations

  • Netherlands

  • Canada

  • United States

  • Belgium

  • Italy

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • dalteparin Subcutaneous

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved